Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2011 AND VI 50 AND IP 7
Results: 6
1
2
Asenapine Pharmacokinetics in Hepatic and Renal Impairment.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 7, p. 471, doi. 10.2165/11590490-000000000-00000
- By:
- Publication type:
- Article
3
Lidocaine (Lignocaine) Dosing Regimen Based upon a Population Pharmacokinetic Model for Preterm and Term Neonates with Seizures.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 7, p. 461, doi. 10.2165/11589160-000000000-00000
- By:
- Publication type:
- Article
4
Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 7, p. 451, doi. 10.2165/11587050-000000000-00000
- By:
- Publication type:
- Article
5
Structural Models Describing Placebo Treatment Effects in Schizophrenia and Other Neuropsychiatric Disorders.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 7, p. 429, doi. 10.2165/11590590-000000000-00000
- By:
- Publication type:
- Article
6
Does Olanzapine Warrant Clinical Pharmacokineti Monitoring in Schizophrenia?
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 7, p. 415, doi. 10.2165/11587240-000000000-00000
- By:
- Publication type:
- Article